Chemical Communications · 2018 · 59 citations · 14 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyCovalent Drug DesignCovalent Inhibitor DesignLigand BindingProtein Scaffold EngineeringProtein-ligand DockingBeta-lactamase InhibitorsClass B Metallo-beta-lactamasesCovalent Enzyme InhibitorsCovalent InhibitorsNovel Antibacterial Drug Discovery
We report the discovery of ebselen-based dual covalent inhibitors of metallo-β-lactamases. Fluorescence and MALDI-TOF analysis suggested that the scaffold could bind to NDM-1 by forming a S-Se bond with Cys221 and an amide bond with Lys224 of NDM-1, thereby exhibiting selective inhibition and labeling against B1 and B2 subclass enzymes in vitro and in vivo.
14
An overview of the kinetic parameters of class B <i>β</i>-lactamases
Antonio Felici, Gianfranco Amicosante, A Oratore et al. · Biochemical Journal · 1993 · 192 citations · Full text